Skip to main content
H.R. 661 119th Congress House

MIRACLE Medical Technology Act of 2025

Official title: To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers… Show full official titleShow less

Official title: To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services.

Introduced: January 23, 2025 Introduced by: Vern Buchanan Republican · Florida See on congress.gov
Health Advanced technology and technological innovationsAdvisory bodiesData collection, sharing, protectionDiplomacy, foreign officials, Americans abroad
More subjectsShow fewer subjects
Employment and training programsHealth promotion and preventive careHealth technology, devices, suppliesIntellectual propertyIsraelManufacturingMedical researchPrescription drugsPublic-private cooperationSupply chain
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 23, 2025
Introduced in House
Jan 23, 2025
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now January 23, 2025

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025

This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 11

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 11 filings →
 Cosponsors 3
All 3 Democratic 2 Republican 1
D
Suozzi, Thomas R.
New York · Dec 23, 2025
 R
Miller-Meeks, Mariannette
Iowa · Jan 23, 2025
 D
Soto, Darren
Florida · Jan 23, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 661: MIRACLE Medical Technology Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-661/
MLA
"H.R. 661: MIRACLE Medical Technology Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-661/.
Bluebook (legal)
H.R. 661, 119th Cong. (2026), https://openamerica.io/bill/119-HR-661/.
Markdown link
[H.R. 661: MIRACLE Medical Technology Act of 2025](https://openamerica.io/bill/119-HR-661/)
Report a problem